Risk Factor — Characteristics Influencing Cancer Odds

In epidemiological and clinical oncology, a risk factor represents a statistically correlated variable associated with an elevated incidence of disease. Risk factors do not guarantee that cancer will occur; rather, they alter the biological probabilities. They act by inducing direct genetic mutations, promoting chronic systemic inflammation, disrupting cellular repair mechanisms, or altering hormonal balances over time.

Risk factors are broadly divided into non-modifiable and modifiable categories. Non-modifiable factors include advancing age, biological sex, inherited genetic mutations (such as BRCA1 or BRCA2 alterations), and family history. Modifiable factors involve lifestyle and environmental exposures, such as tobacco smoking, alcohol consumption, high body mass index, occupational exposure to carcinogens like asbestos, and chronic viral infections.

Recognising risk factors empowers you and your healthcare team to design proactive health strategies. If you have non-modifiable risks, such as a strong family history, doctors can initiate earlier and more frequent cancer screenings or suggest preventive interventions. For modifiable risks, understanding them provides actionable targets—such as quitting smoking or managing body weight—that significantly reduce your lifetime risk of primary tumours or secondary malignancies.

Risk factors themselves are not biological tests, but they are evaluated using medical history questionnaires, lifestyle assessments, and genetic screening tools. When non-modifiable risk factors like family history are suspected, clinicians perform germline genetic testing via blood or saliva to detect inherited variants like BRCA1, BRCA2, or mismatch repair gene mutations. Biomarker tests also screen for carcinogenic infections like hepatitis B, hepatitis C, and high-risk HPV strains.

Risk factors relate to virtually every cancer type. Tobacco smoking is the preeminent risk factor for lung, bladder, and pancreatic cancers. Human papillomavirus (HPV) infection is directly linked to cervical, anal, and head and neck cancers. Excessive ultraviolet radiation exposure drives cutaneous melanoma, while inherited mutations dramatically increase lifetime risks for familial breast, ovarian, and Lynch syndrome-associated colorectal cancers.

While risk factors primarily influence prevention and diagnosis, they also impact clinical care plans. An ongoing modifiable risk, such as active smoking, can impair tissue healing, diminish radiotherapy efficacy, and increase treatment toxicity. Identifying an inherited genetic risk factor (like a BRCA mutation) may dictate the choice of surgical interventions (such as bilateral risk-reducing mastectomy) or guide the selection of targeted therapies like PARP inhibitors.